⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for OH2 Injection in Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: OH2 Injection in Melanoma

Official Title: To Evaluate a Phase III Study of OH2 Versus Investigator-selected Salvage Chemotherapy or Best Supportive Care in Melanoma Patients Who Had Failed Standard Therapy

Study ID: NCT05868707

Conditions

Melanoma

Study Description

Brief Summary: To evaluate the efficacy of OH2 injection in patients with unresectable or metastatic melanoma who have failed at least second-line standard therapy, using investigator-selected salvage chemotherapy or best supportive care (BSC) as controls.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Peking University Cancer Hospital, Beijing, Beijing, China

Chongqing University Cancer Hospital, Chongqing, Chongqing, China

Fujian Cancer Hosptial, Fuzhou, Fujian, China

Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China

Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China

Hainan Cancer Hospital, Haikou, Hainan, China

The Fourth Hospital of Hebei Medical University and Hebei Tumor Hospital, Shijiazhuang, Hebei, China

The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

The Third People's Hospital of Zhengzhou, Zhengzhou, Henan, China

Hubei Cancer Hospital, Wuhan, Hubei, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China

Hunan Cancer Hospital, Changsha, Hunan, China

Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

Jilin Cancer Hospital, Changchun, Jilin, China

The first hospital of Jilin University, Changchun, Jilin, China

The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China

Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

The Affiliated Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China

Weifang People's Hospital, Weifang, Shandong, China

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

West China Hospital of Sichuan University, Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China

The Affiliated Cancer Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China

Yunnan Cancer Hospital, Kunming, Yunnan, China

Cancer Hospital Of The University Of Chinese Academy Of Sciences Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: